DNA-based Influenza Vaccine in the Elderly

Summary

The purpose of this study is to determine whether FVH1, a DNA-based influenza vaccine, will be safe and generally well tolerated in healthy elderly adult volunteers and will result in greater immunogenicity when used to prime the immune response to a dose of a trivalent inactivated seasonal vaccine.

Timeline

Start

2012-06

Primary completion

2014-08

Completion

2015-03

Drugs

Indications